 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$14.06 |
$14.28 |
$13.17 |
$13.73 |
389.40K | | 04/22/2024 |
$13.80 |
$14.52 |
$13.58 |
$14.37 |
278.60K | | 04/23/2024 |
$14.40 |
$14.85 |
$14.11 |
$14.53 |
216.80K | | 04/24/2024 |
$14.66 |
$14.76 |
$14.19 |
$14.21 |
97.00K | | 04/25/2024 |
$14.05 |
$14.50 |
$13.77 |
$13.82 |
185.40K |
|
|
| UroGen Pharma is a biotechnology company focused on developing and commercializing solutions that treat urothelial and specialty cancers. Co. has developed RTGel® reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based technology that has the potential to improve therapeutic profiles of existing drugs. Co.'s Jelmyto® (mitomycin) for pyelocalyceal solution, and its UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer, respectively. | |
|
UroGen Pharma (URGN) has the following price history information. Looking back at URGN historical stock prices for the last five trading days, on April 19, 2024, URGN opened at $14.06, traded as high as $14.28 and as low as $13.17, and closed at $13.73. Trading volume was a total of 389.40K shares. On April 22, 2024, URGN opened at $13.80, traded as high as $14.52 and as low as $13.58, and closed at $14.37. Trading volume was a total of 278.60K shares. On April 23, 2024, URGN opened at $14.40, traded as high as $14.85 and as low as $14.11, and closed at $14.53. Trading volume was a total of 216.80K shares. On April 24, 2024, URGN opened at $14.66, traded as high as $14.76 and as low as $14.19, and closed at $14.21. Trading volume was a total of 97.00K shares. On April 25, 2024, URGN opened at $14.05, traded as high as $14.50 and as low as $13.77, and closed at $13.82. Trading volume was a total of 185.40K shares.
URGN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into UroGen Pharma shares, starting with a $10,000 purchase of URGN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/05/2017 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$14.00 |
|
| End price/share: |
$13.82 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-1.29% |
|
| Average Annual Total Return: |
-0.19% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$9,868.17 |
|
| Years: |
6.98 |
|
|
|
| Date |
Close |
| 04/19/2024 | $13.73 | | 04/22/2024 | $14.37 | | 04/23/2024 | $14.53 | | 04/24/2024 | $14.21 | | 04/25/2024 | $13.82 |
|
|
